A report of two rare carbapenem-resistant strains in the stool sample of the same patient
10.13602/j.cnki.jcls.2025.01.07
- VernacularTitle:同一患者粪便样本检出2种少见碳青霉烯类耐药菌株
- Author:
Yuanyuan LI
1
;
Rong ZHANG
;
Weifeng SHI
Author Information
1. 河南科技大学第一附属医院检验科,河南 洛阳 471003
- Publication Type:Journal Article
- Keywords:
carbapenem resistance;
Klebsiella pneumoniae;
Atlanta subterranean;
blaNDM;
blaIMP
- From:
Chinese Journal of Clinical Laboratory Science
2025;43(1):35-39
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the genomic characteristics of Klebsiella pneumoniae carrying blaNDM-1 and Atlanta subterranean carry-ing blaIMP-4 isolated from the stool sample of the same patient and elucidate their resistance mechanisms.Methods The minimum in-hibitory concentrations(MIC)of the isolated strains were detected by the micro-broth dilution method.The NG-Test CARBA-5 was used to detect the phenotype of carbapenemases.The genomic characteristics of the strains were analyzed by the whole genome sequen-cing(WGS)and bioinformatics analysis.Results The isolated Klebsiella pneumoniae was resistant to most antibiotics.Atlanta subter-ranean was resistant to meropenem and ertapenem,but sensitive to imipenem.The two strains were susceptible to polymyxin,tigecy-cline,amikacin,ciprofloxacin,and aztreonam.The WGS analysis showed that Klebsiella pneumoniae belonged to ST1040 type and car-ried 8 resistance genes,including blaNDM-1,aac(6')-Ib-cr.v2,aadA16,aadA2,qnrS1,arr-3,sul1 and dfrA27,and 4 plasmid repli-cons such as lncR,lncU,lncFIA(Hl1)and lncFIB(K).Atlanta subterranean carried two resistance genes(blaIMP-4 and qnrS1)and 1 plasmid replicon(lncN).The analysis results of virulence factors showed that Klebsiella pneumoniae carried virulence factors such as fimbrium,capsule,and siderophore.Atlanta subterranean carried virulence factors such as fimbrium,flagella,lipopolysaccharides,and endotoxins.Conclusion The Atlanta subterranean producing blaIMP-4 enzyme and Klebsiella pneumoniae producing blaNDM-1 enzyme are isolated from the stool sample of the same patient,and their genomic characteristics are analyzed.The emergence of new carbapen-em-resistant strains poses a huge challenge to clinical treatment and infection prevention and control.The screening and detection of carbapenemase genes should be strengthened.
